Principles and guidelines for surgeons: Management of cutaneous malignant melanoma

European Journal of Surgical Oncology

Volumn 23, Issue 6, 1997, Pages 550-558

  Kroon, Bin B R ^a,d   Nieweg, Omgo E ^a   Hoekstra, Harald J ^b   Lejeune, Ferdy J ^c  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Ctr Pluridisciplinaire d'Oncologie   (Switzerland)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Chemotherapy; Guidelines; Malignant melanoma; Radiotherapy; Surgery

Indexed keywords

CANCER RISK; CANCER STAGING; CANCER SURVIVAL; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LYMPH NODE DISSECTION; MELANOMA; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SKIN BIOPSY; SURGEON; SURGICAL TECHNIQUE;

EID: 0031458163     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(97)93237-6     Document Type: Article

References (18)

1. Rümke Ph, Van Everdingen JJ, on behalf of the Dutch Melanoma Working Party. Consensus on the management of melanoma of the skin in the Netherlands. Eur J Cancer 1992; 28: 600-4.
2. MacKie RM, Osterlind A, Ruiter D, et al. Report on consensus meeting of the EORTC Melanoma Group on educational needs for primary and secondary prevention of melanoma in Europe. Eur J Cancer 1991; 27: 1317-23.
3. Tersmette AC, Coebergh JWW, Casparic-van Velsen IJA, Ruiter DJ, Van der Rhee HJ, Welvaart K. Invasive cutaneous melanoma in the Netherlands, 1989-1990. Eur J Cancer Prevention 1996; 5: 69-74.
4. Incidence of Cancer in the Netherlands, 1992. Utrecht: Vereniging van Integrale Kankercentra, 1995.
5. Levi F, Te VC, Randimbison L, Lavecchia C. Trends in cancer incidence and mortality in Vaud, Switzerland, 1974-1993. Ann Oncol 1996; 7: 497-504.
6. MacKie R, Hunter JAA, Aitchison TC. Cutaneous malignant melanoma, Scotland, 1979-89. Lancet 1992; 339: 971-5.
7. Armstrong BK, English DR. Epidemiologic studies. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S-J (eds) Cutaneous Melanoma (2nd edn). Philadelphia: J.B. Lippincott, 1992: 12-26.
8. Boyle P, Maisonneuve P, Dore JF. Epidemiology of malignant melanoma (Review). Br Med Bull 1995; 51: 523-47.
9. Autier P. Epidemiology of melanoma. In: Lejeune FJ, Chaudhuri PK, Das Gupta TK (eds) Malignant Melanoma. Medical and Surgical Management. New York: McGraw-Hill, 1994: 1-7.
10. Bartkova J, Lukas J, Guldberg P, et al. The P16-Cyclin D CDK4-PRB pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res 1996; 56: 5475-83.
11. Platz A, Sevigny P, Norberg T, Ring P, Lagerlof B, Ringborg U. Genes involved in cell cycle g(l) checkpoint control are frequently mutated in human melanoma metastases. Br J Cancer 1996; 74: 936-41.
12. Robinson WA, Elefanty AG, Hersey P. Expression of the tumour suppressor genes p15 and p16 in malignant melanoma. Melanoma Res 1996; 6: 285-9.
13. NIH Consensus Conference. Precursors to malignant melanoma. JAMA 1984; 251: 1864-6.
14. Rhodes AR, Weinstock MA, Fitzpatrick TB, Mihm MC, Sober AJ. Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA 1987; 258: 3146-54.
15. Evans RD, Kopf AW, Lew RA, et al. Risk factors for the development of malignant melanoma. Review of case-control studies. J Dermatol Surg Oncol 1988; 14: 393-407.
16. Autier P, Doré JF, Lejeune F, et al. Recreational exposure to sunlight and lack of information as risk factors for cutaneous malignant melanoma. Results of an European Organization for Research and Treatment of Cancer (EORTC) case-control study in Belgium, France and Germany. Melanoma Res 1994; 4: 79-85.
17. Osterlind A, Tucker MA, Stone BJ, Jensen OM. The Danish case-control study of cutaneous malignant melanoma. II. Importance of UV-light exposure. Int J Cancer 1988; 42: 319-24.
18. Elwood JM. Melanoma and sun exposure: contrast between intermittent and chronic exposure. World J Surg 1992; 16: 157-65.